Veklury — Class I drug recall D-0005-2025
Terminated recall by Gilead Sciences, Inc., reported 2024-10-09, distributed nationwide. Presence of Particulate Matter: Presence of glass particle.
| Recall number | D-0005-2025 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Gilead Sciences, Inc., Foster City, CA, United States |
| Recall initiated | 2024-09-19 |
| Classified | 2024-10-03 |
| Reported by FDA | 2024-10-09 |
| Terminated | 2025-07-29 |
| Distributed | Nationwide (US) |
| Quantity | 105,000 vials |
| Reason classes | foreign material, specification failure |
| NDC | 61958-2901, 61958-2901-02, 61958-2902, 61958-2902-02 |
| Lot numbers | 47035CFA |
| Expiration dates | 2025-11 |
Product
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
Reason for recall
Presence of Particulate Matter: Presence of glass particle.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0005-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.